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Colloidal carriers for intravenous drug targeting: 
Plasma protein adsorption patterns on surface-modified 
latex particles evaluated by two-dimensional 
polyacrylamide gel electrophoresis 
Targeting to specific sites of the body via colloidal carriers is sought in order 
to reduce drug side effects. The adsorption of plasma proteins on intrave- 
nously injected particles is regarded as the key factor in explaining their organ 
distribution: total bound protein, or, more likely, the presence of specific pro- 
teins and their conformation, are expected to influence macrophage uptake. 
Polystyrene beads, 60 nm in diameter, were used as model carriers; their sur- 
face was differentially modified by adsorption of increasingly hydrophilic 
block copolymers, poloxamers 184, 188 and 407. After incubation in plasma, 
the patterns of protein adsorption onto coated beads were analyzed by high- 
resolution two-dimensional polyacrylamide gel electrophoresis (2-D PAGE). 
The behavior of some representative proteins was monitored, including 
albumin, fibrinogen, IgG, factor B and the apolipoproteins, A-I, A-IV, C-111, E 
and J. The more hydrophobic the particles, the larger the total amount of 
bound protein. However, this correlation was not valid for all of the analyzed 
protein species, which proves that it is insufficient to look only at physico- 
chemical data to predict organ distribution. On the contrary, it is essential to 
use 2-D PAGE to establish the correlation between adsorbed proteins and car- 
rier behavior in vivo. 
1 Introduction 
Colloidal carriers such as nanoparticles are a promising 
approach to drug targeting to specific organs of the body 
[l] in order to reduce side effects, e .g .  in tumor therapy. 
The drug is incorporated in the polymeric nanoparticle 
which is composed of polymers that are biodegradable 
in the body (e. g. polylactide). After intravenous injection 
plasma proteins are immediately adsorbed onto the parti- 
cles. These protein adsorption patterns are regarded 
as the key in their subsequent organ distribution. 
Depending on the particle surface properties, certain pro- 
teins will be preferentially adsorbed, leading to the adhe- 
rence of the particle to cells with the appropriate 
receptor on the surface (Fig. 1). After attachment to the 
cell the nanoparticle is internalized by pinocytosis or 
phagocytosis and will release the drug inside the target 
cell. Carriers with different protein patterns will be 
recognized by different macrophage subpopulations 
(“differential adsorption”, [2]). Carriers not recognized by 
macrophages circulate in the blood and can be used as 
circulating depots for the controlled release of drugs. 
The adsorption pattern acquired after intravenous injec- 
tion depends on the physicochemical properties of the 
particles [2, 31. In vivo clearance of the particles by the 
mononuclear phagocytic system (MPS) was reported to 
increase with increasing hydrophobicity [4, 51: hydro- 
phobic particles were taken up by liver and spleen 
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macrophages within S min after injection in NZW rab- 
bits (approximately 90% and 1-5% of the injected dose, 
respectively [ 11). Controlled surface modification which 
reduces hydrophobicity decreases the uptake by the liver 
and spleen, and highly hydrophilic particles circulate in 
the blood. This correlation is only valid, however, 
if chemical groups which may lead to immunological 
recognition are absent (for details see [l]). 
A simple but efficient method for carrier surface modifi- 
cation is the irreversible adsorption of hydrophilic block 
copolymers such as poloxamers (Fig. 2). They adsorb 
with their hydrophobic center part (poly(propy1ene 
oxide)) on the particle surface, while the hydrophilic 
poly(ethy1ene oxide) chains protrude into the dispersion 
medium, exposing a hydrophilic surface. The hydrophi- 
licit): increases with increasing molecular weight and 
length of the ethylene oxide chains of the poloxamer. 
This allows the controlled adjustment of surface proper- 
ties. In addition, the nonionic adsorption layer covers 
the original charges on the particle surface, creating non- 
charged carriers in physiological salt solution [l], which 
is claimed to be an additional prerequisite for the reduc- 
tion of liver and spleen uptake [6,  71. 
Despite the importance of the adsorption pattern for in 
vivo organ distribution and for successful drug targeting, 
up to now limited data is available, in general only from 
one-dimensional sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) experiments [8]. TO 
detect single proteins the adsorption patterns on the 
drug carriers were analyzed using high resolution two- 
dimensional (2-D PAGE) according to Hochstrasser [9] .  
To establish the correlation between particle properties, 
protein adsorption layer, and organ distribution, it is 
sensible to use standard particles as model carriers, 
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which are well-defined in their surface properties and 
not biodegradable. The latter avoids superposition of 
effects of in vivo organ distribution and particle degrada- 
tion by the body enzymes durin gamma scintigraphy 
studies. Polystyrene latex particles (60 nm), surface- 
modified by coating with block copolymers poloxamer 
184, 188 and 407, were used as a model system (Fig. 2). 
2 Materials and methods 
2.1 Reagents 
Polystyrene latex particles were from Polysciences (War- 
rington, USA). The block copolymers poloxamer 184, 
188 and 407 were a gift from ICI (Manchester, UK). 
Human plasma was drawn from healthy male volunteers 
and stored at -30°C. For 2-D PAGE all chemicals were 
of analytical grade. Acrylamide, N, N, N ,  N-tetramethyl- 
ethylenediamine (TEMED), ammonium persulfate and 
piperazine diacrylamide (PDA) were obtained from Bio- 
Rad (Munich, Germany). Carrier ampholytes pH 3.5-10 
and 4-8 were from BDH (Poole, UK), pH 9-11 from 
LKB (Bromma, Sweden). Cholamidopropyldimethylhy- 
droxypropanesulfonate (CHAPS), Nonidet-P 40 and Tris 
were from Sigma (Deisenhofen, Germany). All other 
chemicals according to [9] were either from Fluka 
Chemie AG (Buchs, Switzerland) or Merck (Darmstadt, 
Germany). 
2.2 Apparatus 
The determination of particle size was performed by 
photon correlation spectroscopy using a Malvern spectro- 
Figure I .  Principle of drug targeting 
using colloidal carriers for intravenous 
injection: The drug is incorporated 
inside the nanoparticle or alternatively 
in the capillaries of a sponge-like nano- 
particle. The particle surface is modified 
by irreversible adsorption of block copo- 
lymers. Depending on  the surface pro- 
perties, certain blood proteins are prefer- 
entially adsorbed, leading to the adhe- 
rence of the particle to cells with appro- 
priate receptors. The particle hydropho- 
bicity - and, subsequently, protein 
adsorption pattern and organ distribu- 
tion - can be altered by using block 
copolymers of different molecular 
weight (see Fig. 2). 
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Figure 2. The poloxamer block copolymers adsorb on hydrophobic 
polystyrene drug carriers with their hydrophobic center part (poly(pro- 
pylene oxide), PO). The poly(ethy1ene oxide) (EO) chains protrude 
into the dispersion medium generating a hydrophilic surface. The 
hydrophilicity of the newly formed drug carrier surface increases with 
increasing ethylene oxide chain length and molecular weight of the 
poloxamers used. 
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meter RR 102 in connection with a K 7025 correlator 
(Malvern Instruments, Malvern, UK). Isoelectric 
focusing using carrier ampholytes was carried out in a 
model 175 chamber from Bio-Rad (Munich, Germany). 
For SDS-PAGE the Bio-Rad Protean I1 chamber, the 
casting chamber (160 X 160 X 1.5 mm gels) and gradient 
pourer model 395 were used. Both the first- and second- 
dimensional separation were run with a Bio-Rad 1000/ 
500 power supply. Silver-stained gels were scanned with 
a laser densitometer (Personal Densitometer from 
Molecular Dynamics, Krefeld, Germany). Data was pro- 
cessed on a SUN SPARCstation 10 using the MELANIE 
software [lo]. 
2.3 Sample preparation and 2-D PAGE 
Particle coating was carried out by mixing equal volumes 
of polystyrene (PS) latex particles (2.5% w/v) with polo- 
xamer 184, 188 or 407 (2.0% w/v, aqueous solution) and 
incubation overnight. Two hundred pL of these disper- 
sions (PS-184, PS-188 and PS-407) were mixed with 5 
mL human citrate plasma in a centrifugation tube and 
incubated for 5 min at 37°C. The particle-to-plasma ratio 
was chosen to be relatively similar to the ratio used in 
the in viva organ distribution studies [l, 11, 121. In vivo 
0.6 mL coated particles were injected in a 2-3 kg NZW 
rabbit (blood volume - 120 mL). However, such low 
particle to plasma ratios were not used in this study 
because of the difficulties to remove such tiny amounts 
(60 nm nanoparticles) from large plasma quantities. The 
ratio of 200 pL particle suspension to 5 mL plasma 
allows relatively easy separation with high particle yield 
even after multiple washing. After having established 
the basic method, future studies will include the varia- 
tion of the particle-to-plasma ratio to assess any competi- 
tive phenomena of protein adsorption. For this purpose 
separation methods need to be established allowing the 
analysis of low particle concentrations in plasma. The 
particles were centrifuged for 90 min at 15000 g. The 
supernatant was discarded, the particle pellet redispersed 
in 1.5 mL distilled water and the suspension transferred 
into Eppendorf vials. After centrifugation and discarding 
the supernatant a second washing step using distilled 
water was performed. Future studies will also include 
phosphate buffered saline (PBS) and Ringer solution as 
washing media to study possible desorption effects 
during sample preparation. The pellet obtained was dis- 
persed in a protein solubilizing solution containing SDS 
and dithioerythritol (DTE), and the sample was pro- 
cessed like standard plasma samples. 2-D PAGE was per- 
formed essentially as described previously [9]. Plasma 
(0.3 pL) or 40 pL of the particle suspension were separ- 
ated on the first-dimensional gels using carrier ampho- 
lytes. After SDS-PAGE the gels were silver-stained [9]. 
For a detailed methodological assessment of the protein 
adsorption onto drug carriers and its analysis using 2-D 
PAGE refer to Blunk et al. (submitted for publication). 
That publication also deals with adsorption onto chemi- 
cally different particles. 
3 Results and discussion 
Intensive physicochemical characterization of the sur- 
face-modified polystyrene particles was performed previ- 
ously [l, 131. The thickness of adsorbed layers increased 
from poloxamer 184 to 188 and 407 (2.4,7.6 and 12.0 nm, 
respectively). This increase was correlated with a 
decrease in hydrophobicity as determined by hydro- 
phobic interaction chromatography (HIC). The HIC 
results showed marked differences in terms of surface 
hydrophobicity. The most hydrophobic poloxamer 184- 
coated particles could only be eluted from very hydro- 
philic columns (ethyl-agarose), whereas poloxamer 107- 
coated particles eluted from hydrophobic columns (such 
as pentyl-agarose) proved to be the most hydrophilic. It 
is concluded that the EO chains of poloxamer 407 are 
sufficiently long to shield the hydrophobic regions in the 
adsorption layer. Quantitative parameters to express the 
hydrophobicity of the particles were the elution volume, 
the percentage eluted from a column with buffer, per- 
centage washed off from the column with 0.1% Triton 
X-100 solution, percentage irreversibly bound to a 
column and the ratio of the areas under the curves of 
the elution to the wash peak, calculated for each column. 
For example, for the poloxamer 407, 188 and 184 coated 
particles the elution volumes of 4.5 mL (= void volume 
of column) and 6.5 mL and no elution, respectively, 
were obtained from a propyl-agarose column (for details 
see [l]. 
The adsorption patterns of the three kinds of particles 
clearly differed from plasma bulk solution (Fig. 3). This 
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Figure 3. 2-D PAGE pattern of human plasma. The proteins exempla- 
rily discussed in this paper are indicated: 1, factor B; 2, transfemn; 
3, albumin; 4, fibronogen B chain; 5, IgG y chain; 6 ,  al-antitrypsin; 
7, ApoA-IV; 8, haptoglobin fi chain; 9, ApoJ; 10, ApoE; 11, Ig light 
chains; 12, ApoA-I; 13, ApoC-111. The analysis was performed essen- 
tially as described in [9]. First-dimensional isoelectric focusing was 
performed with carrier ampholytes, generating a pH gradient 4-8. The 
polyacrylamide rods contained 4% T and 2.6O/o C (PDA as cross-linker). 
Focusing was allowed to proceed for 52.3 Vh/cm2. Second-dimen- 
sional SDS-PAGE slab gels (160 X 160 X 1.5 mm) contained an 
8-l8% T linear acrylamide gradient with 2.6% C (PDA as cross-linker) 
resolving proteins from 6 to 250 kDa. The gels were stained with silver 
according to [9]. 
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observation is in agreement with data in the literature 
obtained using other analytical methods [3, 141. Corn- 
paring the eluates from particles to plasma, the propor- 
tion of certain proteins is reduced or increased. The frac- 
tion of albumin and al-antitrypsin (percentage of the Comparing the three particle gels, differences were 
total protein detected on the gel) is drastically reduced found in the total amount of bound protein as well as in 
on the particles compared to plasma, and the hapto- the qualitative and quantitative composition of the 
globin B chain is hardly detectable. In contrast, trans- 
ferrin and apolipoprotein C-I11 are examples for en- 
riched proteins (Fig. 4 a-c). 
Figure 4. Plasma protein adsorption pattern of 60 nm polystyrene par- 
ticles (PS) which were coated with poloxamer (a) 184, (b) 188 and 
(c) 407. The numbers of the proteins indicated are the same as in 
Fig. 2. 
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adsorption patterns. The differences in the total amount 
of protein adsorbed were assessed in a semi-quantitative 
manner on the basis of spot size and intensity of silver 
staining. At present a modified Lowry assay is about to 
be established to obtain absolute amounts of protein 
bound to differently modified particles. The total 
amount of adsorbed protein was found to be the largest 
on the most hydrophobic PS-184 (970 cpm units, deter- 
mined using MELANIE software). The amount of 
adsorbed protein was distinctly lower on PS-188 (490 
cpm units) and PS-407 (390 cpm units). This correlates 
with the physicochemical characterization by HIC. In 
order to exemplify the performance of the method it is 
now focused on single proteins. For most of them, again, 
the largest amount was detected on PS-184, IgG and 
transferrin being the major proteins. Only for apolipopro- 
teins C-I11 and A-I similar amounts as on PS-188 were 
detected, for apo A-I the adsorption being even a little 
lower (Fig. 4 a-c, Table 1). 
Comparing PS-188 to PS-407, transferrin, fibrinogen and 
factor B were found in similar amounts (Fig. 4 b-c, 
Table 1). For apolipoproteins C-111, A-I and J the lowest 
binding was detected on the least hydrophobic PS-407, 
whereas apolipoprotein A-IV and E were adsorbed the 
least on PS-188 of intermediate hydrophobicity. Relative- 
ly larger fractions were found on PS-407 (Fig. 5). 
The adsorption behavior of the latter apolipoproteins as 
well as of transferrin and apo C-I11 is therefore not cor- 
related with surface hydrophobicity. This demonstrates 
that determination of surface hydrophobicity may be of 
limited use to predict the in vivo organ distribution of 
colloidal drug carriers. In contrast to reports in the litera- 
ture [4, 51 a straigthforward correlation between surface 
hydrophobicity and macrophage uptake cannot be con- 
firmed. Particle hydrophobicity is related to the total 
amount of protein adsorbed but provides no information 
about differential adsorption leading to differential 
macrophage uptake. 
In general, using surface hydrophobicity as a parameter 
to differenciate between different particles with regard 
to their interaction with proteins is possible only for par- 
Table 1: Examples of plasma proteins adsorbed on 60 nm polystrene (PS) model drug carriers, surface-modified with different poloxamers. 
Adsorption was detected by 2-D PAGE, numbers represent cpm units as a quantitative measure determined by MELANIE software. 
Model drug carrier Factor B Transferrin Fibrinogen p Albumin ApoC-I11 IgG heavy Ig light chains 
chains 
PS 60 nm + Poloxamer 184 3 69 18 20 28 73 141 
PS 60 nm + Poloxamer 188 1 48 11 15 27 45 82 
PS 60 nm + Poloxamer 407 1 44 8 10 7 34 78 
Model drug carrier AuoA-I AuoJ AuoA-IV AooE 
PS 60 nm + Poloxamer 184 28 55 23 18 
PS 60 nm + Poloxamer 188 34 21 1 3 
PS 60 nm + Poloxamer 407 8 2 6 8 
PS 60 nm + 
Poloxamer 184 
PS 60 nm + 
Poloxamer 188 
PS 60 nrn + 
Poloxamer 407 
Figuw 5. Zoom of the middle left areas of the gels in Fig. 4: PS 60 nm + Poloxamer 184 (left), PS 60 nm + Poloxamer 188 (middle), PS 60 nm + 
Poloxamer 407 (right). For all apolipoproteins a large amount was detected on  PS-184, only for ApoA-I it was slightly smaller than on PS-188. 
ApoA-I and ApoJ were adsorbed the least on PS-407, Apo J being hardly detectable. In contrast, the smallest amounts of ApoA-TV and ApoE 
were observed on  PS-188. 
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ticles possessing a similar chemical composition on the 
surface. Surface chemistry strongly determines protein 
adsorption [ 151. When comparing the adsorption patterns 
of poloxamer coated and uncoated particles, the differ- 
ences between poly(ethy1ene oxide)/poly(propylene 
oxide) and polystyrene lead to qualitatively and quantita- 
tively different results (Blunk et al., submitted for publi- 
cation). 
Differences in the adsorption patterns could be detected 
but their relevance to organ distribution needs to be 
assessed. At first sight, the heavy protein adsorption ob- 
served on the most hydrophobic poloxamer 184 coated 
particles seems to be in agreement with the in vivo liver 
uptake observed with other hydrophobic particles. The 
clearly reduced amount of adsorbed protein on more 
hydrophilic particles seems to correlate with reduction, 
or avoidance, of liver uptake by more hydrophilic parti- 
cles [ll]. However, not the total amount of protein but 
the composition of the protein layer is regarded as the 
important factor. For example, cell culture experiments 
indicate the existence of an opsonin which mediates spe- 
cifically the uptake by liver macrophages and a second 
opsonin for the uptake by spleen macrophages [16-181. 
Opsonization of erythrocytes with IgG led to preferential 
uptake by spleen macrophages and with IgM to pre- 
ferential uptake by liver macrophages [ 191. Proteins 
present in large amounts on the particles, e.g. IgG, are 
the most likely to affect organ distribution. There may 
also be a minimum concentration for certain proteins 
required to cause an effect, and proteins present in 
minute amounts are unlikely to be of importance. Fur- 
thermore, differences in the conformation of proteins - 
possibly generated by different surface chemistry and/or 
neighboring proteins in the adsorption layer - may also 
be a determining factor for the fate of the carriers in vivo. 
The assumption that the composition of the layer (single 
proteins, conformation of proteins) is the main factor is 
supported by the organ distribution of poloxamine 908 
and poloxamer 407 coated particles. They adsorb small 
amounts of total protein resulting in similar adsorption 
patterns, but differences are still detectable (Blunk et af.,  
submitted for publication). Both particles are able to 
avoid liver/spleen uptake but the poloxamine 908 parti- 
cles circulate in blood [ll], whereas the poloxamer 407 
coated particles accumulate in bone marrow [12]. 
4 Concluding remarks 
High resolution 2-D PAGE was able to detect major dif- 
ferences in the adsorption patterns on particles surface- 
modified with chemically similar block copolymers. The 
total amount of adsorbed protein was related to surface 
hydrophobicity, whereas quantitative differences for 
single proteins could not be linearly correlated to the dif- 
ferences in surface hydrophobicity. Therefore analysis of 
the adsorption patterns appears to be a straightforward 
and more sensible approach to understand differences in 
organ distribution than studies solely based on physico- 
chemical characterization. In the near future further data 
processing will be performed using the MELANIE soft- 
ware 1161. Nevertheless, a physicochemical characteriza- 
tion of the particles is needed to complement 2-D PAGE 
analysis, especially when comparing particles similar in 
the chemical composition of the surface. 
The final goal will be to establish the correlation 
between physicochemical particle properties, acquired 
protein adsorption after intravenous injection and the 
resulting organ distribution. Having established this cor- 
relation, particles can be targeted by controlled adjust- 
ment of their surface properties. After intravenous injec- 
tion they will adsorb the protein species which are re- 
sponsible for the accumulation in the desired target 
tissue, e,g. bone marrow. In comparison to homing via 
antibodies and lectins, targeting using “differential 
adsorption” [2] is a simpler - and therefore a more feas- 
ible - approach to site-specific drug delivery. 
We wish to thank Mrs. Heike Betinski-Eggert f o r  her tech- 
nical assistance and Mr. Riidiger Smal fo r  preparing the 
photographs. 
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